The US office of patents and trademarks has issued notice of allowance to Ampio Pharmaceuticals for diabetic macular edema (DME) drug Optina patent. The company has also received similar patent from the Canadian Intellectual Property ...
Tags: Ampio, allowance for DME drug, Optina patent